FORT LAUDERDALE, Fla., Dec. 06, 2016 -- VPR Brands LP, (OTC pink:VPRB ) announces today that it has recently filed a Trade Mark application, serial number 87251694, for the launch of its SAFRx Brand of packaging containers for the medical and recreational marijuana industry. The company has seen an increased demand among producers and sellers of cannabis for packages that comply with various state and child safety regulations. SAFRx Brand will produce compliant, functional and aesthetically appealing packaging for the cannabis market.
Kevin Frija, CEO of VPR Brands LP, said, "We are always looking for opportunities to better serve our existing customer base with products they need. Due to our rapid growth within the cannabis oil packaging segment, supplying tanks and cartridges, we believe it is a natural extension to offer packages and containers for dry leaf cannabis as well as edibles and to become a one-stop shop within the Cannabis industry supply chain. “We believe there is a great opportunity for our SAFRx Brand products to become the go-to market leader.”
SAFRx Brand packaging will focus on being child proof, smell proof, convenient and discrete. We will specialize in creating full branded and coordinated product packaging lines for licensed growers and extractors . Look for available SAFRx Brand packages as early as January 2017 on www.SAFRx.com.
About VPR Brands, LP:
VPR Brands is a technology holding company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Electronic cigarettes (also known as ecigs) are devices which deliver nicotine through atomization, or vaping of e-liquids and without smoke and other chemicals constituents typically found in traditional tobacco burning cigarette products. For more information about VPR Brands, please visit the company on the web at www.vprbrands.com
Forward looking statements:
This news release contains statements that involve expectations, plans or intentions and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. The company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Contact: Kevin Frija Chief Executive Officer and Chief Financial Officer VPR Brands, LP 954.715.7001 Email: [email protected]


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Italy Fines Apple €98.6 Million Over App Store Dominance
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



